First Trust Advisors
TGTX icon

First Trust Advisors’s TG Therapeutics TGTX Stock Holding History

First Trust Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.16M Buy
166,654
+116,707
+234% +$4.78M 0.01% 1249
2026
Q1 		$1.66M Sell
49,947
-38,545
-44% -$1.15M ﹤0.01% 1997
2025
Q4 		$2.64M Sell
88,492
-55,211
-38% -$1.8M ﹤0.01% 1754
2025
Q3 		$5.19M Sell
143,703
-53,678
-27% -$1.77M ﹤0.01% 1362
2025
Q2 		$7.1M Sell
197,381
-25,411
-11% -$946K 0.01% 1194
2025
Q1 		$8.78M Sell
222,792
-52,704
-19% -$1.77M 0.01% 1090
2024
Q4 		$8.29M Buy
275,496
+247,145
+872% +$7.09M 0.01% 1126
2024
Q3 		$663K Sell
28,351
-128,477
-82% -$2.81M ﹤0.01% 2108
2024
Q2 		$2.79M Sell
156,828
-11,734
-7% -$187K ﹤0.01% 1554
2024
Q1 		$2.56M Buy
168,562
+129,995
+337% +$2.07M ﹤0.01% 1624
2023
Q4 		$659K Sell
38,567
-103,213
-73% -$1.2M ﹤0.01% 2079
2023
Q3 		$1.19M Sell
141,780
-16,968
-11% -$237K ﹤0.01% 1908
2023
Q2 		$3.94M Buy
+158,748
New +$4.1M ﹤0.01% 1345
2021
Q4 		– Sell
-21,720
Closed -$723K – 2591
2021
Q3 		$723K Sell
21,720
-22,404
-51% -$693K ﹤0.01% 2153
2021
Q2 		$1.71M Sell
44,124
-35,656
-45% -$1.4M ﹤0.01% 1865
2021
Q1 		$3.85M Buy
79,780
+5,886
+8% +$283K ﹤0.01% 1391
2020
Q4 		$3.84M Sell
73,894
-7,776
-10% -$263K 0.01% 1228
2020
Q3 		$2.19M Sell
81,670
-26,540
-25% -$611K ﹤0.01% 1325
2020
Q2 		$2.11M Buy
+108,210
New +$1.74M ﹤0.01% 1344

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors's TGTX Position: Q2 2026 in Review

First Trust Advisors increased its TG Therapeutics (TGTX) stake by 234% in Q2 2026, buying an estimated $4.78M and bringing the position to 166,654 shares worth $9.16M. The position accounts for 0.01% of the portfolio, ranked #1249.

First Trust Advisors first reported a position in TGTX in Q2 2020 and has held it in 19 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • First Trust Advisors held 166,654 shares of TG Therapeutics worth $9.16M as of Q2 2026.
  • First Trust Advisors bought 116,707 TG Therapeutics shares in Q2 2026, an estimated $4.78M.
  • TG Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1249 holding.
  • First Trust Advisors first reported a position in TG Therapeutics in Q2 2020 and has held it in 19 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.